Recent Events
-
22 January 2021Description: On 22nd January nine students from the PhD Program Regenerative Sciences...
Press releases
EU fördert MHH-Biomediziner mit Millionen
Privatdozent Dr. Nico Lachmann erhält renommierte Auszeichnung „ERC Starting Grant“ [more]
Durchbruch in der Stammzellforschung
Internationale Forschergruppe stellt hoch potente Zellen von Mensch und Schwein her / Neue Möglichkeiten für die regenerative Medizin Wissenschaftlerinnen und Wissenschaftler verwenden für ihre Forschungsergebnisse das Wort... [more]
Almost two million euros for liver research in Düsseldorf and Hannover
New network seeks to enhance understanding of genetic causes of cholestasis – and develop treatment options [more]
MHH researchers aim to use gene therapy to treat hearing deafness
Professor Schambach was awarded approximately two million euros from the European Union for his “iHEAR” project / New gene therapies shall protect children and adults from hearing loss [more]
Abitur und dann? Die MHH und Partnerinstitutionen bieten das Freiwillige Jahr in der Wissenschaft an
Informationsveranstaltung am 18. Februar um 16 Uhr in der Hochschule Die Medizinische Hochschule Hannover (MHH) bietet ab September zum neunten Mal ein Freiwilliges Jahr in der Wissenschaft (FWJ) für Abiturientinnen und... [more]
Neues Blut dank neuer Technik
Advances made in blood cell production / MHH researchers pave the way for new therapy to combat infection / Publication in Nature Communications Blood is very special stuff. It performs a variety of roles: for example, red... [more]
REBIRTH researchers identify potential drug to treat rare condition
A substance has been identified that alleviates symptoms of a rare vascular disease called cerebral cavernous malformation (CCM). It was found thanks to comprehensive analysis – using a mouse model – within a consortium headed by... [more]
System for transporting donor lungs approved in USA following trial
In a clinical trial called INSPIRE, a large international team of investigators led by physicians at Hannover Medical School (MHH) has shown that the transport and storage of donor lungs using the Organ Care System (OCS) –... [more]
Hannoversche Forscher wollen „unsichtbare“ Organe schaffen
Für Menschen, die ein Spenderorgan transplantiert bekommen, beginnt ein neuer Lebensabschnitt mit einem gesunden Organ. Doch sie leben auch mit dem Risiko, dass ihr Körper das gespendete Organ wieder abstößt. Das passiert... [more]
Like leaves in a stream: researchers explore the biomechanics of heart valve development
Over the course of an 80-year life, the human heart pumps more than 200 million litres of blood through the body. This impressive feat is crucially dependent on the formation of cardiac valves, which are absent in the early... [more]
An exciting prospect: patients cured by their own cells?
Altering patients’ own cells so they can replace defective or absent cells – researchers at Hannover Medical School (MHH) have moved a step closer to achieving this. The scientists are investigating hereditary pulmonary alveolar... [more]
Organ Care System: MHH physicians treat diseased lung outside the body
The growing resistance of pathogens to antibiotics means that, in an increasing number of cases, doctors are out of alternative treatment options for severe pneumonia. Medics at Hannover Medical School (MHH) have, for the first... [more]
Hilfiker-Kleiner joins prestigious academic body
Professor Denise Hilfiker-Kleiner, dean of research at Hannover Medical School (MHH) and leader of a REBIRTH unit, became a new member of Germany’s Council of Science and Humanities (WR) with effect from 1 February 2018. Federal... [more]
Gene therapy for rare blood condition
Scientists at Hannover Medical School (MHH) have achieved a first: they have developed a successful cell and gene therapy for a genetic infectious disease. It appears to be a promising treatment for a rare and life-threatening... [more]
How are artificial lungs implanted?
For people with certain serious lung conditions, a lung transplant is the only curative treatment option. However, only a small proportion of patients can receive this treatment, as there are fewer and fewer organ donors... [more]